Relay Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Relay Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
  • Relay Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 133M shares, a 9.16% increase year-over-year.
  • Relay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 123M shares, a 9.22% increase from 2022.
  • Relay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 112M shares, a 18% increase from 2021.
  • Relay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 95.1M shares, a 123% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 133M +11.1M +9.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 131M +9.52M +7.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 123M +10.3M +9.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 122M +11.3M +10.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 122M +13M +12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 121M +13M +12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 112M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 111M +18.2M +19.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 109M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 108M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 92.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.